Pharmaceutical naming is both art and science—requiring creative exploration, regulatory rigor, and trademark precision.

At Brandsymbol, we built MOSAIQ™ to fuse these dimensions into a single, seamless workflow.

By bringing together strategy, AI, and human expertise, MOSAIQ™ delivers faster, safer, and more inspired shortlists—so you save time, avoid late-stage risks, and launch with confidence.

Step 1: Strategy First — Grounded in Brand Truth

Every great name starts with clarity. We align on your asset’s positioning, therapeutic area, and emotional tone, ensuring the creative direction reflects your brand’s purpose—not just a sound.

Example: A recent cardiology initiative began with the goal of communicating stability and patient reassurance, guiding both the linguistic tone and creative territories explored.

AI then analyzes competitor landscapes and linguistic spaces, identifying gaps and opportunities that guide creative exploration.

Client benefit: This alignment ensures every name is strategically anchored—reducing rework and accelerating decision-making.

Step 2: Creative Intelligence — AI Meets Human Insight

MOSAIQ™ uses advanced AI models to explore linguistic and thematic territories at scale, generating thousands of name options in seconds. But the goal isn’t volume—it’s relevance.

Our creative team refines these AI-generated ideas, ensuring every candidate reflects your desired tone, strategy, and patient connection.

Client benefit: You get more meaningful shortlists faster, without sacrificing creative depth or strategic precision.

Step 3: Regulatory Prescreening — Safety Starts Early

Most agencies wait until late in the process to check for safety risks. MOSAIQ™ flips that script.

Using rule-based systems aligned with FDA, EMA, MHRA, and other authorities, our platform runs early POCA checks, stem analyses, and word construction reviews—flagging risks before they reach client review.

Client benefit: You avoid costly late-stage rejections and keep your launch timeline on track.

Step 4: Trademark Filtering — Reducing Surprises

MOSAIQ™ integrates tools like Corsearch™ and NameCheck™ to screen thousands of potential conflicts across more than 1,000 databases in real time.

This early legal screening ensures high-risk candidates are removed long before you see them.

Client benefit: You receive a shortlist that’s creative, defensible, and clearance-ready—minimizing last-minute surprises.

Step 5: Refinement & Shortlist — Confidence in Every Name

Finally, our experts step in to fine-tune the strongest candidates.

We evaluate each for pronunciation, cultural resonance, and emotional impact, ensuring your final shortlist connects with patients and professionals alike.

Example: In a recent oncology project, our refinement process surfaced names emphasizing patient empowerment and simplicity—critical differentiators in a crowded therapeutic landscape.

Client benefit: You gain a curated, globally viable shortlist that reflects deep creative and regulatory intelligence.

From Chaos to Clarity

Pharma naming doesn’t have to feel like searching for a needle in a haystack.

MOSAIQ™ transforms the naming process into a guided, intelligent journey—from strategy to shortlist—delivering names that are creative, compliant, and ready for global clearance.

Ready to See MOSAIQ™ in Action?

Book a 20-minute walkthrough and experience how AI + IQ can change the way you build and launch your next brand—faster, safer, and with greater confidence.